NCT00990145View on ClinicalTrials.gov

Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

March 31, 2009

Study Completion Date

September 30, 2009

Conditions
MRSA, SSTI
Interventions
DRUG

EDP-322

Trial Locations (1)

Unknown

PPD Phase I Unit, Austin

Sponsors
All Listed Sponsors
lead

Enanta Pharmaceuticals, Inc

INDUSTRY

NCT00990145 - Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter